Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha,China.
Cardiovasc Drugs Ther. 2011 Oct;25(5):451-9. doi: 10.1007/s10557-011-6342-4.
Diabetes mellitus is a common metabolic disease characterized by a state of oxidative stress, inflammation and endothelial dysfunction. This malady can lead to a number of complications such as ischemic heart disease, nephropathy, neuropathy, retinopathy and impaired wound healing. The etiology of diabetic complications is multifactorial, and is closely associated with oxidative stress and inflammation. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a receptor for oxidized low density lipoprotein (ox-LDL), plays critical roles in multiple signal transduction pathways and is involved in the process of oxidative stress and inflammation. Recent studies provide important insights into the roles of LOX-1 in the development and progression of diabetic vasculopathy which is the underlying mechanism of diabetic complications. In this review, we summarize mechanistic studies, mainly related to LOX-1, on the development and progression of diabetes mellitus and its cardiovascular complications.
糖尿病是一种常见的代谢疾病,其特征是氧化应激、炎症和内皮功能障碍的状态。这种疾病会导致许多并发症,如缺血性心脏病、肾病、神经病、视网膜病变和伤口愈合受损。糖尿病并发症的病因是多因素的,与氧化应激和炎症密切相关。凝集素样氧化低密度脂蛋白受体-1(LOX-1)是氧化低密度脂蛋白(ox-LDL)的受体,在多种信号转导途径中发挥关键作用,并参与氧化应激和炎症过程。最近的研究为 LOX-1 在糖尿病血管病变(糖尿病并发症的潜在机制)的发展和进展中的作用提供了重要的见解。在这篇综述中,我们总结了与 LOX-1 相关的机制研究,主要涉及糖尿病及其心血管并发症的发展和进展。